Skip to main content
Tetra Bio-Pharma Inc. logo

Tetra Bio-Pharma Inc. — Investor Relations & Filings

Ticker · TBPMQ ISIN · CA88166Y1007 LEI · 5299000CYH3P8XC2UO53 TSX Manufacturing
Filings indexed 720 across all filing types
Latest filing 2020-02-07 Regulatory Filings
Country CA Canada
Listing TSX TBPMQ

About Tetra Bio-Pharma Inc.

https://tetrabiosciences.com/

Tetra Bio-Pharma is a biopharmaceutical company specializing in the discovery and development of cannabinoid-derived drugs and medicinal plant-based products. The company maintains an advanced pipeline encompassing biopharmaceuticals, natural health, and veterinary products. Clinical programs are focused on therapeutic areas such as inflammation, pain management (including alternatives to opioids), and ophthalmology. Tetra emphasizes rigorous clinical trials and scientific evidence, utilizing novel approaches, unique mechanisms of action, and high-quality delivery methods to address unmet patient needs.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – French.pdf
Regulatory Filings
2020-02-07 English
Interim MD&A - French.pdf
Regulatory Filings
2020-02-07 English
Material change report - English.pdf
Regulatory Filings
2020-02-07 English
Documents incorporated by reference not previously filed – French.pdf
Regulatory Filings
2020-02-07 English
Documents incorporated by reference not previously filed – French.pdf
Regulatory Filings
2020-02-07 English
Documents incorporated by reference not previously filed – French.pdf
Regulatory Filings
2020-02-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.